These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 992909)

  • 1. Kinetics of the response of spleen cells from tumor-bearing animals in an in vivo tumor neutralization assay.
    Gabizon A; Small M; Trainin N
    Int J Cancer; 1976 Dec; 18(6):813-9. PubMed ID: 992909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discussion paper: in vitro augmentation of tumor immunity in a murine methylcholanthrene sarcoma system.
    Yarlott MA; McKhann CF
    Ann N Y Acad Sci; 1976; 277(00):533-40. PubMed ID: 187102
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased resistance in splenectomized mice to a methylcholanthrene-induced tumour.
    Chang RW; Turk JL
    Br J Cancer; 1977 Jun; 35(6):768-76. PubMed ID: 871366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-embryo immunization on methylcholanthrene-induced sarcoma growth in BALB/c mice.
    Parmiani G; Lembo R
    Int J Cancer; 1974 Oct; 14(4):555-64. PubMed ID: 4617712
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the spleen in the immunity to a chemically induced sarcoma in C3H mice.
    Bard DS; Pilch YH
    Cancer Res; 1969 May; 29(5):1125-31. PubMed ID: 5781103
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
    Frbes JT; Nakaw Y; Smith RT
    J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in spleen morphology and lymphoid cell activity during tumor progression.
    Yamagishi H; Pellis NR; Macek C; Kahan BD
    Eur J Cancer (1965); 1980 Nov; 16(11):1417-26. PubMed ID: 7227418
    [No Abstract]   [Full Text] [Related]  

  • 12. Release of immature cells from the thymus during solid tumor growth: identification by assay of TdT activity.
    Small M; Lasser-Weiss M; Daniel V
    J Immunol; 1979 Jul; 123(1):259-62. PubMed ID: 312875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to a 3-methylcholanthrene-induced fibrosarcoma in the C57BL/6 mouse: in vivo analysis by the adoptive tumor neutralization test.
    Poupon MF; Lespinats G; Kolb JP; Payelle B
    J Natl Cancer Inst; 1979 Apr; 62(4):989-94. PubMed ID: 311871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.
    Ishikawa Y; Fukushima M; Sato T; Komaba M; Yagihashi H
    Tohoku J Exp Med; 1971 Feb; 103(2):195-201. PubMed ID: 5580594
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunospecificity of altered initial arrest patterns of circulating cancer cells in tumor-bearing mice.
    Weiss L; Glaves D
    Int J Cancer; 1976 Dec; 18(6):774-7. PubMed ID: 1036490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune responses to methylcholanthrene-induced fibrosarcoma in BALB/c mice.
    Bhatnagar RM; Zabriskie JB; Rausen AR
    J Exp Med; 1975 Oct; 142(4):839-55. PubMed ID: 1185107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas.
    Mantovani A; Evans R; Alexander P
    Br J Cancer; 1977 Jul; 36(1):35-40. PubMed ID: 889683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of anti-tumor immune responses in rats immunized with solubilized tumor-associated antigens from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Int J Cancer; 1979 Mar; 23(3):358-65. PubMed ID: 437918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.